- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06395571
GI Symptoms in Infants Fed GMF or CMF
Common Gastrointestinal Symptoms in Healthy Infants Receiving Goat Milk-based Formula or Cow Milk-based Formula: a Double-blind, Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Anecdotal evidence shows that the use of goat milk-based infant formula decreases discomfort of infants with cow's milk related symptoms. In this double-blind, randomized controlled trial, gastrointestinal comfort in infants fed goat milk-based infant formula (GMF) or cow's milk-based infant formula (CMF) was studied.
Fifty-six healthy infants aged 3-12 months were followed for 24 weeks. Stool consistency, regurgitation frequency and crying duration were measured weekly using an adapted version of the Cow's Milk-related Symptom Score (CoMiSS®) where only the items for these scores were used. Blood hemoglobin levels were measured at the start and at the end of the intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bahia
-
Salvador, Bahia, Brazil
- Daycare center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- gestational age 37-42 weeks
- 3-12 months old at enrollment
- should have consumed cow's milk-based products during the 48 hours prior to the baseline visit to exclude cow's milk allergic infants
Exclusion Criteria:
- metabolic or chronic disease or congenital malformation, serious concurrent illness that would interfere with study treatment, (i.e. sepsis, pneumonia with respiratory failure, cardiac failure)
- infant's parent(s) or primary caregiver(s) diagnosed with major depression
- infant's weight for length at baseline >|3| z-score indexes according to WHO criteria
- infants enrolled in another interventional clinical research study
- infants diagnosed with cow's milk allergies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Goat milk-based infant formula
Experimental group receives goat milk-based formula for 24 weeks
|
Goat milk-based infant formula fed at age appropriate quantities for 24 weeks
|
|
Active Comparator: Cow's milk-based infant formula
Control group receives cow's milk-based formula for 24 weeks
|
Cow's milk-based infant formula formula fed at age appropriate quantities for 24 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastrointestinal symptoms
Time Frame: 24 weeks, measured weekly
|
Stool consistency, regurgitation frequency and crying duration as measured by an adapted Cow's Milk-related Symptom Score®, where a higher score indicates more severe symptoms.
|
24 weeks, measured weekly
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood hemoglobin levels
Time Frame: 24 weeks, measured at start and end
|
Blood hemoglobin levels before and after intervention
|
24 weeks, measured at start and end
|
|
WHO z-score of weight-for-age
Time Frame: 24 weeks, measured monthly
|
Weight measured to the nearest 5.0 grams with clothes and diaper removed.
|
24 weeks, measured monthly
|
|
WHO z-score of length-for-age
Time Frame: 24 weeks, measured monthly
|
Body length without shoes, measured lying down to the nearest centimeter with a neonatometer.
|
24 weeks, measured monthly
|
|
WHO z-score of head circumference-for-age
Time Frame: 24 weeks, measured monthly
|
Head circumference measured with flexible non-stretching tape to the nearest centimeter.
|
24 weeks, measured monthly
|
|
WHO z-score of weight-for-length
Time Frame: 24 weeks, measured monthly
|
Weight and length measured as described above combined.
|
24 weeks, measured monthly
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hugo da Costa Ribeiro, Dr., Hospital Professor Edgard Santos, Federal University of Bahia, Salvador, Brazil
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P19-009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Diseases
-
Medstar Health Research InstituteRecruitingGastrointestinal Cancer | Gastrointestinal Tumor | Gastrointestinal Surgery | Gastrointestinal Tumor SurgeryUnited States
-
Umeå UniversityCompletedFunctional Gastrointestinal DisorderSweden
-
The University of Texas Medical Branch, GalvestonCompletedGastrointestinal Disorders, Functional
-
Fondazione Don Carlo Gnocchi OnlusCatholic University of the Sacred Heart; University of PadovaRecruitingFunctional Gastrointestinal Disorders (FGIDs)Italy
-
Chang Gung Memorial HospitalNew Bellus EnterprisesUnknownNeoplasm | Functional Gastrointestinal DisorderTaiwan
-
Campus Bio-Medico UniversityRecruitingGastrointestinal Cancer | Gastrointestinal Hemorrhage | Gastrointestinal Lesions | Gastrointestinal Injury | Gastrointestinal Perforation | Gastrointestinal UlcerItaly
-
Massachusetts General HospitalEnrolling by invitationGastrointestinal Dysfunction | Gastrointestinal DiseaseUnited States
-
Dr Anne PayneUniversity of LondonUnknownFunctional Gastrointestinal Disorders in ChildrenUnited Kingdom
-
Jiangxi University of Traditional Chinese MedicineThe First Affiliated Hospital of Nanchang University; Second Affiliated Hospital... and other collaboratorsCompletedGastrointestinal DiseaseChina
-
Zealand University HospitalRecruiting
Clinical Trials on Goat milk-based infant formula
-
Ausnutria Hyproca B.V.Not yet recruitingInfections | Quality of Life | Gastrointestinal Tolerance | Gastrointestinal Symptoms | AnthropometricsSaudi Arabia
-
Medical University of WarsawAusnutria Hyproca B.V.Not yet recruitingGastrointestinal Diseases | Infant Nutrition DisordersPoland
-
Ausnutria Hyproca B.V.Active, not recruitingGrowth | Infection | Gastrointestinal Symptoms | Allergy SymptomsSaudi Arabia
-
Ausnutria Hyproca B.V.HM hospitalesCompleted
-
Danone NutriciaCompleted
-
Dairy Goat Co-operative (N.Z.) LimitedKlinikum der Universität MünchenActive, not recruitingDermatitis, Atopic | Child Development | Infant Development | Eczema, InfantilePoland, Spain, Germany
-
Mead Johnson NutritionBeijing Kangchen TechnologiesTerminated
-
Dairy Goat Co-operative (N.Z.) LimitedChulalongkorn UniversityActive, not recruitingConstipation - Functional | Infant Development | Gastrointestinal Disorder, Functional | Colic, Infantile | Regurgitation, GastricThailand
-
Abbott NutritionInstitute of Child HealthCompleted